{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:47:48Z","timestamp":1789991268011,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.molmed.2003.12.008","type":"journal-article","created":{"date-parts":[[2004,1,6]],"date-time":"2004-01-06T05:49:09Z","timestamp":1073368149000},"page":"85-91","source":"Crossref","is-referenced-by-count":47,"title":["Non-invasive measurement of brain damage in a primate model of multiple sclerosis"],"prefix":"10.1016","volume":"10","author":[{"given":"Bert A.","family":"'t Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Vogels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert P.M.","family":"Brok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Blezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2003.12.008_BIB1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2003.12.008_BIB2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/135245859800400301","article-title":"Neuropathology in multiple sclerosis: new concepts","volume":"4","author":"Lassmann","year":"1998","journal-title":"Mult. Scler."},{"key":"10.1016\/j.molmed.2003.12.008_BIB3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2003.12.008_BIB5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1600-065x.2001.1830114.x","article-title":"Non-human primate models of multiple sclerosis","volume":"183","author":"Brok","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2003.12.008_BIB6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1474-4422(03)00505-2","article-title":"New and emerging treatment options for multiple sclerosis","volume":"2","author":"Polman","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB7","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/80516","article-title":"Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand","volume":"6","author":"Bielekova","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2003.12.008_BIB8","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","article-title":"Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2","volume":"47","author":"van Oosten","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2003.12.008_BIB9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1359-6446(02)02268-7","article-title":"Whole-animal cellular and molecular imaging to accelerate drug development","volume":"7","author":"Contag","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.molmed.2003.12.008_BIB10","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1172\/JCI18926","article-title":"Tolerance: of mice and men","volume":"111","author":"Sachs","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2003.12.008_BIB11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0167-5699(00)01627-3","article-title":"A new primate model for multiple sclerosis in the common marmoset","volume":"21","author":"'t Hart","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.molmed.2003.12.008_BIB12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00019052-200306000-00019","article-title":"The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system","volume":"16","author":"'t Hart","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB13","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI200317477","article-title":"Heterologous immunity provides a potent barrier to transplantation tolerance","volume":"111","author":"Adams","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2003.12.008_BIB14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/sj.gt.3302017","article-title":"Gene therapy in nonhuman primate models of human autoimmune disease","volume":"10","author":"'t Hart","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.molmed.2003.12.008_BIB15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ilar.44.2.153","article-title":"Assessment of cognitive and motor deficits in a marmoset model of stroke","volume":"44","author":"Marshall","year":"2003","journal-title":"ILAR J."},{"key":"10.1016\/j.molmed.2003.12.008_BIB16","first-page":"11","article-title":"The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease","volume":"20","author":"Jenner","year":"1986","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.molmed.2003.12.008_BIB17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02778005","article-title":"Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy","volume":"8","author":"Baker","year":"1994","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s001090050103","article-title":"Creation of a model for multiple sclerosis in Callithrix jacchus marmosets","volume":"75","author":"Genain","year":"1997","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molmed.2003.12.008_BIB19","series-title":"The Brain of the Common Marmoset (Callithrix jacchus). A Stereotactic Atlas","author":"Stephan","year":"1980"},{"key":"10.1016\/j.molmed.2003.12.008_BIB20","series-title":"Marmosets and tamarins in biological and biomedical research","year":"1997"},{"key":"10.1016\/j.molmed.2003.12.008_BIB21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1098-2345(199912)49:4<285::AID-AJP1>3.0.CO;2-X","article-title":"What is a marmoset?","volume":"49","author":"Haig","year":"1999","journal-title":"Am. J. Primatol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ana.410370415","article-title":"Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis","volume":"37","author":"Massacesi","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB23","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1172\/JCI118368","article-title":"Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate","volume":"96","author":"Genain","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2003.12.008_BIB24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1034\/j.1600-065x.2001.1830113.x","article-title":"Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus","volume":"183","author":"Genain","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2003.12.008_BIB25","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4049\/jimmunol.165.2.1093","article-title":"Myelin\/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule","volume":"165","author":"Brok","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB26","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1073\/pnas.95.20.11745","article-title":"The common marmoset: a new world primate species with limited Mhc class II variability","volume":"95","author":"Antunes","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2003.12.008_BIB27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1600-065X.1999.tb01403.x","article-title":"Major histocompatibility complex class II polymorphisms in primates","volume":"167","author":"Bontrop","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2003.12.008_BIB28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0002-9440(10)65606-4","article-title":"Histopathological characterization of magnetic resonance imaging- detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus)","volume":"153","author":"'t Hart","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-510X(00)00490-1","article-title":"Demyelination and axonal damage in a non-human primate model of multiple sclerosis","volume":"184","author":"Mancardi","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.molmed.2003.12.008_BIB30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO;2-K","article-title":"Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation","volume":"46","author":"Raine","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-5728(98)00024-1","article-title":"Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus)","volume":"86","author":"Laman","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/1097-0320(20011201)45:4<294::AID-CYTO10002>3.0.CO;2-C","article-title":"An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin","volume":"45","author":"Brok","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.molmed.2003.12.008_BIB33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s002510100362","article-title":"Characterization of the expressed immunoglobulin IGHV repertoire in the New World marmoset Callithrix jacchus","volume":"53","author":"von Buedingen","year":"2001","journal-title":"Immunogenetics"},{"key":"10.1016\/j.molmed.2003.12.008_BIB34","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.4049\/jimmunol.169.10.5415","article-title":"Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs","volume":"169","author":"de Vos","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/5532","article-title":"Identification of autoantibodies associated with myelin damage in multiple sclerosis","volume":"5","author":"Genain","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2003.12.008_BIB36","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.4049\/jimmunol.162.4.2384","article-title":"Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis","volume":"162","author":"McFarland","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB37","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0198-8859(01)00346-9","article-title":"The major histocompatibility complex influences the ethiopathogenesis of MS-like disease in primates at multiple levels","volume":"62","author":"'t Hart","year":"2001","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0198-8859(97)00252-8","article-title":"HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis","volume":"59","author":"Yu","year":"1998","journal-title":"Hum. Immunol."},{"issue":"Suppl 2","key":"10.1016\/j.molmed.2003.12.008_BIB39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000049146","article-title":"Imaging of white matter lesions","volume":"13","author":"Barkhof","year":"2002","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.molmed.2003.12.008_BIB40","first-page":"965","article-title":"Serial MR imaging of experimental autoimmune encephalomyelitis induced by human white matter or by chimeric myelin-basic and proteolipid protein in the common marmoset","volume":"20","author":"Jordan","year":"1999","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB41","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/ana.410380514","article-title":"Monocyte\/macrophage differentiation in early multiple sclerosis lesions","volume":"38","author":"Br\u00fcck","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.410420515","article-title":"Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology","volume":"42","author":"Bruck","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB43","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.4049\/jimmunol.169.11.6554","article-title":"Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody","volume":"169","author":"Brok","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB44","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.4049\/jimmunol.167.5.2942","article-title":"Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses","volume":"167","author":"Boon","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB45","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/1521-4141(200208)32:8<2218::AID-IMMU2218>3.0.CO;2-0","article-title":"Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12)","volume":"32","author":"Laman","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd728","article-title":"Metabonomics: a platform for studying drug toxicity and gene function","volume":"1","author":"Nicholson","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2003.12.008_BIB47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/rheumatology\/37.3.314","article-title":"Collagen-induced arthritis in rhesus monkeys: evaluation of markers for inflammation and joint degradation","volume":"37","author":"'t Hart","year":"1998","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB48","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1365-2249.2001.01487.x","article-title":"Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys","volume":"124","author":"Brok","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000008241","article-title":"Immunological time-course of gadolinium-enhancing MRI lesions in patients with multiple sclerosis","volume":"44","author":"Giovannoni","year":"2000","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.molmed.2003.12.008_BIB50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1191\/135245899678846230","article-title":"Biological markers in body fluids for activity and progression in multiple sclerosis","volume":"5","author":"Sorensen","year":"1999","journal-title":"Mult. Scler."},{"key":"10.1016\/j.molmed.2003.12.008_BIB51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/135245859800400329","article-title":"Myelin basic protein-like material in the urine of multiple sclerosis patients: relationships to clinical and neuroimaging changes","volume":"4","author":"Whitaker","year":"1998","journal-title":"Mult. Scler."},{"key":"10.1016\/j.molmed.2003.12.008_BIB52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/abbi.2000.1764","article-title":"p-Cresol sulfate is the dominant component of urinary myelin basic protein like material","volume":"377","author":"Cao","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.molmed.2003.12.008_BIB53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-510X(03)00080-7","article-title":"1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like disease","volume":"212","author":"'t Hart","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.molmed.2003.12.008_BIB54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/(SICI)1099-128X(199609)10:5\/6<425::AID-CEM442>3.0.CO;2-S","article-title":"Partial linear fit: a new NMR spectroscopy pre-processing tool for pattern recognition applications","volume":"10","author":"Vogels","year":"1996","journal-title":"J. Chemometrics"},{"key":"10.1016\/j.molmed.2003.12.008_BIB55","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1021\/ac00261a016","article-title":"Discriminant analysis by double stage principal component analysis","volume":"55","author":"Hoogerbrugge","year":"1983","journal-title":"Anal. Chem."},{"key":"10.1016\/j.molmed.2003.12.008_BIB56","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1021\/ac00277a009","article-title":"Nonsupervised numerical component extraction from pyrolysis mass spectra of complex mixtures","volume":"56","author":"Windig","year":"1984","journal-title":"Anal. Chem."},{"key":"10.1016\/j.molmed.2003.12.008_BIB57","first-page":"427","article-title":"High resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development","volume":"31","author":"Nicholson","year":"1987","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.molmed.2003.12.008_BIB58","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"\u2018Metabonomics\u2019: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1016\/j.molmed.2003.12.008_BIB59","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd728","article-title":"Metabonomics: a platform for studying drug toxicity and gene function","volume":"1","author":"Nicholson","year":"2002","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491403002806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491403002806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T14:12:28Z","timestamp":1682604748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491403002806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S1471491403002806"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2003.12.008","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}